Skip to content

Mechanisms Regulating Wound Vascularization

Mechanisms Regulating Wound Vascularization

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00737321
Enrollment
36
Registered
2008-08-19
Start date
2008-08-31
Completion date
2018-12-31
Last updated
2021-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wounds and Injuries

Keywords

Impact of ischemia, Impact of stress and, Identify patterns of gene expression

Brief summary

This pilot study is designed to assess the impact of ischemia/ diminished wound vascularization and stress on wound healing by comparing patterns of gene expression in specific cell types critical to wound healing biology, e.g. macrophages or endothelial cells.

Detailed description

Chronic wounds affect approximately 2% of the U.S. population at any given time. Animal models can not simulate the complex set of pre-existing conditions in each individual that results in failed wound healing. Therefore, human subjects must be used to obtain valid data. Adequate wound vascularization that permits blood vessels to deliver oxygen to the wound is a requirement for wound healing to occur. This protocol will attempt to gain greater understanding of the mechanisms of chronic wounds through 3 specific aims: 1) identify the angiogenic mechanisms in wound site macrophages, which are required for healing, 2) determine the impact of stress and glucocorticoid resistance on endothelial cell and macrophage biology and ultimately wound healing outcomes, 3) identify patterns of gene expression in wound endothelial cells that are found in healing versus non-healing wounds. This data will be correlated with the wound oxygenation status to determine the impact of wound vascularization on the observed biological responses.

Interventions

PROCEDURESamples will be collected

wound tissue biopsy, blood samples, saliva collection and wound VAC sponge (if applicable).

Sponsors

Gayle Gordillo
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 69 Years
Healthy volunteers
No

Inclusion criteria

* Age 18-69 years * ischemic wound group * non-ischemic wound group * diabetes with good glycemic control * lower extremity wound

Exclusion criteria

* Age greater ≥ 70 years * End stage renal disease * Unable to provide informed consent * Pregnant women * Therapeutically anticoagulated * Prisoners * Periwound TcOM \< 25mmHg * Spinal cord injury * Taking immunosuppressive medications * Individuals with current diagnosis of a major psychiatric illness (e.g.schizophrenia,psychosis) * Severe protein malnutrition- pre-albumin \< 10 mg/dl or albumin \< 2 g/dl * Diabetes with poor glucose control-defined as hgb A1c \> 8.4%

Design outcomes

Primary

MeasureTime frameDescription
Changes in Gene Expression Profile in Healing versus Non-healing Wounds12 weeksWound tissue biopsies, saliva, serum samples and wound sponges will be obtained at an initial time point, at the midpoint of the study and near the end of wound closure over a 12 week window. If the wound closes quickly, i.e. less than 4 weeks then only 2 biopsies will be obtained.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026